When a chronic illness shows up in a family, one of the first questions people ask is whether it runs in the genes. For myasthenia gravis, an autoimmune disease that disrupts communication between nerves and muscles, the honest answer sits in a kind of middle ground that catches a lot of people off guard. Myasthenia gravis is not hereditary in the way conditions like cystic fibrosis or Huntington's disease are, where a specific gene mutation passes directly from parent to child according to a predictable pattern. And yet, genetics is far from irrelevant here. Family history, specific immune-related genes, and even other autoimmune conditions in your relatives all factor into the picture in ways that are genuinely worth understanding.
This article untangles what current research actually says about the genetics of myasthenia gravis, clears up the confusion with two genuinely inherited look-alike conditions, and explains what your family history realistically does, and does not, tell you about your own risk. For background on what early myasthenia gravis symptoms look like, see our companion piece on the early signs of myasthenia gravis.
The Short Answer: Not Hereditary, But Not Entirely Unrelated to Genetics Either
According to MedlinePlus Genetics, a resource maintained by the National Institutes of Health, in most cases myasthenia gravis is not inherited and occurs in people with no history of the disorder in their family at all. This is a fairly direct and reassuring starting point for most people newly grappling with a diagnosis or worried about family risk.
But that same authoritative source goes on to add an important nuance: gene variations that affect immune system function likely affect a person's risk of developing myasthenia gravis and other autoimmune disorders, even though researchers have not pinned down exactly which genes are responsible or how strongly they contribute. According to the Muscular Dystrophy Association, although myasthenia gravis and other autoimmune diseases are not hereditary, genetic susceptibility does appear to play a real role, and it seems likely that genetic factors contribute to how the disease develops in the people who do get it.
In other words, you cannot inherit myasthenia gravis itself the way you might inherit eye color or a specific genetic disorder. What you can inherit is a slightly higher baseline susceptibility to autoimmune disease in general, myasthenia gravis included, largely through genes involved in regulating the immune system. This distinction, between inheriting a disease directly and inheriting a subtle predisposition toward immune dysregulation, is really the crux of why this topic so often gets oversimplified in either direction.
What the Genetics Actually Show
HLA Genes and Immune Recognition
The genetic thread researchers have studied most extensively in myasthenia gravis involves a family of genes called human leukocyte antigens, or HLA. According to Myasthenia-Gravis.com, a patient resource reviewed by clinical experts, researchers have linked myasthenia gravis to this group of genes, which manage the immune system and help it distinguish between the body's own proteins and proteins made by outside invaders like viruses and bacteria.
Specific HLA variants have shown up repeatedly across genetic studies of myasthenia gravis. According to Rare Disease Advisor, genetic tests have identified specific HLA alleles linked with susceptibility to myasthenia gravis, as is true for most autoimmune disorders, and certain polymorphisms, including HLA-DRB1*1501, HLA-DQ5, and a gene called CTLA4, show a more specific association with myasthenia gravis and particular subgroups of the disease. The Muscular Dystrophy Association adds that the antibody-specific subtype known as MuSK antibody-positive myasthenia gravis is particularly associated with the HLA haplotypes DR14 and DQ5, a haplotype referring to a cluster of genes that tend to be inherited together as a set.
Other Immune-Regulating Genes
Beyond the HLA system, researchers have identified several additional genes that appear to nudge risk upward, though none of them function as a single decisive cause on their own. According to Nebula Genomics, genes including PTPN22, which regulates immune cell function, and TNFRSF13B, which is involved in the development and maturation of antibody-producing B cells, have both been associated with increased risk of myasthenia gravis. A more technical genetic review published in the NCBI PMC database describes this as a complex interaction between multiple genetic variants of relatively low individual effect, combined with environmental factors such as viral infections, particularly Epstein-Barr virus, sex hormones, and lifestyle factors like cigarette smoking.
This complexity is precisely why no single gene test can currently tell you whether you will or will not develop myasthenia gravis. The same review notes that disease-associated risk variants also appear in plenty of healthy people who never develop the condition, underscoring that genetics here represents a modest tilt in probability, not a deterministic blueprint.
What Twin Studies Reveal
Perhaps the most genuinely surprising and clarifying piece of evidence comes from research on identical twins, who share virtually all of their DNA. According to the Muscular Dystrophy Association, most studies suggest that when one identical twin has an autoimmune disease, the other twin has less than a 50 percent chance of developing the same condition. If myasthenia gravis, or autoimmune disease more broadly, were driven primarily by genetics in a deterministic way, you would expect identical twins to share these conditions far more consistently than that.
This finding helps explain why doctors and researchers consistently describe genetic susceptibility rather than genetic causation when discussing myasthenia gravis. Genes appear to set a backdrop of relative risk, but something else, whether an infection, a hormonal shift, or another environmental trigger researchers have not fully identified, still seems to be required to actually set the disease in motion in a genetically susceptible person.
How Often Does Myasthenia Gravis Actually Run in Families?
Given everything above, you might reasonably wonder how often myasthenia gravis genuinely does show up more than once in the same family. Research suggests it happens, but the chances remain pretty low.
According to MedlinePlus Genetics, about 3 to 5 percent of people with myasthenia gravis have other family members with either myasthenia gravis or another autoimmune disorder, though the precise inheritance pattern in these cases remains unknown. A separate clinical estimate cited in reporting from MDedge puts this figure somewhat higher, noting that research suggests up to 7 percent of patients have myasthenia gravis specifically, not just any autoimmune disease, somewhere in their family history.
An older but detailed family study published on PubMed examined 44 myasthenia gravis patients and their relatives, finding that 30 percent had a confirmed family history of some autoimmune disease, though myasthenia gravis itself was the specific condition in only one of those cases. Interestingly, the same study found that in every family with a documented autoimmune disease connection, the affected relatives were related to the patient through the maternal line, an intriguing pattern that researchers have continued to explore in the decades since.
A more recent and larger-scale study referenced by Healthline looked at more than 1,000 people with generalized myasthenia gravis across North America and found that the rate of the disease within families was indeed higher than would be expected by pure chance, and that a disproportionate number of patients had a personal or family history of autoimmune disease more broadly. Even so, the same source is careful to add an essential caveat: because myasthenia gravis is a genuinely rare condition overall, even an elevated relative risk within families still translates into a low absolute risk for any individual family member.
Why Autoimmune Diseases Tend to Cluster in Families
Even when myasthenia gravis specifically does not repeat within a family, a broader pattern often does: a tendency toward autoimmune disease generally. According to Myasthenia-Gravis.com, when a member of your family has an autoimmune disease, your own chances of developing some form of autoimmune disease rise, and that risk climbs further the more closely related you are to the affected family member. The same source notes that anywhere from 5 to 10 percent of people living with myasthenia gravis go on to develop a second autoimmune disease themselves, most commonly autoimmune thyroid disease.
This pattern makes more biological sense once you understand what the genes involved, like the HLA family, actually do. Rather than coding for a specific disease, these genes shape how broadly and aggressively the immune system distinguishes "self" from "non-self." A genetic tendency toward overactive or miscalibrated immune surveillance can plausibly express itself as myasthenia gravis in one family member and as a completely different autoimmune condition, such as rheumatoid arthritis or type 1 diabetes, in another. This shared genetic vulnerability across seemingly unrelated autoimmune diseases is explored further in Naturem's discussion of primary versus secondary chronic inflammation, which looks at how the same underlying immune dysregulation can manifest very differently depending on which tissue ends up targeted.
The Two Conditions That Actually Are Hereditary, and Why They Get Confused With MG
Much of the genuine confusion around whether myasthenia gravis is hereditary comes from two other, genuinely inherited conditions that share a strikingly similar name and overlapping symptoms. Understanding the difference clears up a lot of the uncertainty.
Congenital Myasthenic Syndrome
Congenital myasthenic syndrome, often abbreviated CMS, sounds almost identical to myasthenia gravis and produces remarkably similar symptoms, fatigable muscle weakness that worsens with activity and improves with rest, but the underlying cause is entirely different. According to EyeWiki, CMS differs from acquired myasthenia gravis in that it is not antibody mediated, and as a result, immunosuppressive treatment, the cornerstone of standard MG management, is not indicated for treating CMS at all. Instead, the source explains that CMS is caused by a wide variety of inherited or spontaneous mutations across more than 30 identified genes that affect different components of the neuromuscular junction.
According to a detailed clinical reference on ScienceDirect, congenital myasthenic syndromes are usually characterized by autosomal-recessive, and less often dominant, inheritance, meaning they genuinely do follow predictable genetic inheritance patterns, along with a notable absence of myasthenia gravis in the mother and a tendency to appear in multiple siblings within the same family. A direct comparison published by MGteam confirms that genetic testing to identify the specific inherited mutation is one of the standard tools used to diagnose CMS, a test that would be irrelevant for diagnosing autoimmune myasthenia gravis, which instead relies on antibody blood tests not present in CMS at all.
In short, CMS is a true hereditary disorder of the neuromuscular junction, while autoimmune myasthenia gravis is not, even though the two conditions can look strikingly alike to an untrained eye and sometimes even on certain diagnostic tests.
Transient Neonatal Myasthenia Gravis
A second, often-confused condition is transient neonatal myasthenia gravis, which understandably worries many pregnant women who have myasthenia gravis themselves. According to a systematic review published in the NCBI PMC database, this condition is caused by maternal autoantibodies that cross the placenta during pregnancy and temporarily disrupt neuromuscular signaling in the newborn, affecting an estimated 10 to 20 percent of babies born to mothers with myasthenia gravis.
Crucially, this is not genetic inheritance at all, it is a temporary, passive transfer of the mother's own antibodies across the placenta, not a transmission of any gene or mutation. According to the Myasthenia Gravis Foundation of America, as the baby's own immune system gradually replaces these borrowed maternal antibodies, symptoms typically resolve within a few weeks, and the baby grows up with no increased risk of developing myasthenia gravis later in life as a result. This is an important distinction for any expecting mother with myasthenia gravis to understand: even if this temporary condition occurs, it reflects a passing physiological process rather than a hereditary disease being passed down to her child.
What This Means for You and Your Family
If you have myasthenia gravis and are wondering what this all means practically for your children, siblings, or other relatives, the honest, evidence-based summary looks something like this. Your specific diagnosis of myasthenia gravis itself is very unlikely to be directly passed on to your children in the way a single-gene disorder would be. However, your family does likely carry a somewhat elevated, though still modest, genetic tendency toward autoimmune disease in general, meaning relatives may have a slightly higher than average chance of developing some form of autoimmune condition, not necessarily myasthenia gravis specifically.
According to Healthline, treatment for generalized myasthenia gravis is generally very effective, and people with the disease may have no reduction in their life expectancy as a result of appropriately managed treatment, a reassuring point that applies regardless of how the disease developed in the first place. For a deeper look at how myasthenia gravis is treated once diagnosed, see our companion article on common approaches to managing myasthenia gravis symptoms.
If you are concerned about your own family history, whether because a parent, sibling, or child has myasthenia gravis or another autoimmune condition, a conversation with a doctor, and potentially a referral to a genetic counselor, can help put your individual situation into a more precise and personalized context than general population statistics alone can offer.
This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease, nor to provide personalized genetic risk assessment. If you have specific concerns about hereditary or family risk related to myasthenia gravis, please consult a neurologist or genetic counselor for guidance tailored to your individual family history.
Frequently Asked Questions (FAQs)
1. If my mother has myasthenia gravis, will I definitely get it too?
No. Even with a parent diagnosed with myasthenia gravis, the overall likelihood of a child also developing the condition remains low, since myasthenia gravis is not directly inherited in the way single-gene disorders are. What may be somewhat elevated is your general susceptibility to autoimmune disease as a category, though this still translates into a relatively low absolute risk given how rare myasthenia gravis is in the broader population (MedlinePlus Genetics, n.d.; Healthline, 2026).
2. What is the actual difference between myasthenia gravis and congenital myasthenic syndrome?
Myasthenia gravis is an autoimmune disease in which the body's own antibodies attack the neuromuscular junction, and it is not directly hereditary. Congenital myasthenic syndrome, despite causing very similar symptoms, is caused by inherited genetic mutations affecting neuromuscular junction proteins directly, has no connection to antibodies, and does not respond to the immunosuppressive treatments used for myasthenia gravis (EyeWiki, n.d.; MGteam, 2025).
3. Can I pass myasthenia gravis to my baby during pregnancy?
You cannot pass on the disease itself genetically, but a temporary condition called transient neonatal myasthenia gravis can occur in 10 to 20 percent of babies born to mothers with myasthenia gravis, caused by maternal antibodies crossing the placenta. This is not hereditary transmission and typically resolves within a few weeks as the baby's own immune system takes over, with no increased lifelong risk of myasthenia gravis for the child (NCBI PMC, 2024; Myasthenia Gravis Foundation of America, 2024).
4. Is there a genetic test that can predict whether I will develop myasthenia gravis?
Not currently in any reliable, predictive sense. While researchers have identified certain HLA gene variants and other immune-related genes associated with increased susceptibility, these variants are also found in many healthy people who never develop the disease, meaning no single genetic test can accurately predict whether a specific person will or will not develop myasthenia gravis (NCBI PMC, 2013; Nebula Genomics, 2024).
5. Does having myasthenia gravis mean I am likely to develop other autoimmune diseases too?
There is a somewhat increased risk, though it is far from a certainty. Research indicates that approximately 5 to 10 percent of people with myasthenia gravis go on to develop a second autoimmune condition, most commonly autoimmune thyroid disease, reflecting a shared underlying tendency toward immune system dysregulation rather than a direct causal relationship between the two conditions (Myasthenia-Gravis.com, 2022).
References
